Eastwood Bio-Medical Canada Past Earnings Performance
Past criteria checks 0/6
Eastwood Bio-Medical Canada has been growing earnings at an average annual rate of 17.2%, while the Healthcare industry saw earnings growing at 16.2% annually. Revenues have been declining at an average rate of 3.3% per year.
Key information
17.2%
Earnings growth rate
17.2%
EPS growth rate
| Healthcare Industry Growth | -6.7% |
| Revenue growth rate | -3.3% |
| Return on equity | n/a |
| Net Margin | -74.1% |
| Last Earnings Update | 31 Jul 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Eastwood Bio-Medical Canada makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Jul 24 | 1 | 0 | 1 | 0 |
| 30 Apr 24 | 1 | 0 | 1 | 0 |
| 31 Jan 24 | 1 | -1 | 1 | 0 |
| 31 Oct 23 | 1 | -1 | 1 | 0 |
| 31 Jul 23 | 1 | 0 | 1 | 0 |
| 30 Apr 23 | 1 | 0 | 1 | 0 |
| 31 Jan 23 | 1 | 0 | 1 | 0 |
| 31 Oct 22 | 1 | 0 | 1 | 0 |
| 31 Jul 22 | 1 | 0 | 1 | 0 |
| 30 Apr 22 | 1 | 0 | 1 | 0 |
| 31 Jan 22 | 1 | 0 | 1 | 0 |
| 31 Oct 21 | 1 | -1 | 1 | 0 |
| 31 Jul 21 | 1 | -1 | 1 | 0 |
| 30 Apr 21 | 1 | -1 | 1 | 0 |
| 31 Jan 21 | 1 | -1 | 1 | 0 |
| 31 Oct 20 | 1 | -1 | 1 | 0 |
| 31 Jul 20 | 1 | -1 | 1 | 0 |
| 30 Apr 20 | 1 | -1 | 1 | 0 |
| 31 Jan 20 | 1 | -1 | 1 | 0 |
| 31 Oct 19 | 1 | -1 | 1 | 0 |
| 31 Jul 19 | 1 | -1 | 1 | 0 |
| 30 Apr 19 | 1 | -1 | 1 | 0 |
| 31 Jan 19 | 1 | -1 | 1 | 0 |
| 31 Oct 18 | 1 | -1 | 1 | 0 |
| 31 Jul 18 | 0 | -1 | 1 | 0 |
| 30 Apr 18 | 0 | -1 | 1 | 0 |
| 31 Jan 18 | 0 | -1 | 1 | 0 |
| 31 Oct 17 | 0 | 0 | 1 | 0 |
| 31 Jul 17 | 0 | 0 | 1 | 0 |
| 30 Apr 17 | 0 | 0 | 1 | 0 |
| 31 Jan 17 | 0 | -1 | 1 | 0 |
| 31 Oct 16 | 0 | 0 | 1 | 0 |
| 31 Jul 16 | 1 | 0 | 1 | 0 |
| 30 Apr 16 | 1 | 0 | 1 | 0 |
| 31 Jan 16 | 1 | 0 | 1 | 0 |
| 31 Oct 15 | 1 | 0 | 1 | 0 |
| 31 Jul 15 | 1 | 0 | 1 | 0 |
| 30 Apr 15 | 1 | -1 | 1 | 0 |
| 31 Jan 15 | 0 | -1 | 1 | 0 |
| 31 Oct 14 | 0 | -1 | 1 | 0 |
| 31 Jul 14 | 0 | 0 | 1 | 0 |
| 30 Apr 14 | 0 | 0 | 1 | 0 |
| 31 Jan 14 | 1 | 0 | 1 | 0 |
Quality Earnings: EBM is currently unprofitable.
Growing Profit Margin: EBM is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: EBM is unprofitable, but has reduced losses over the past 5 years at a rate of 17.2% per year.
Accelerating Growth: Unable to compare EBM's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: EBM is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (10.4%).
Return on Equity
High ROE: EBM's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.